Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases

Food Chem Toxicol. 2013 Nov:61:215-26. doi: 10.1016/j.fct.2013.07.021. Epub 2013 Jul 18.

Abstract

Resveratrol-a natural polyphenolic compound-was first discovered in the 1940s. Although initially used for cancer therapy, it has shown beneficial effects against most cardiovascular and cerebrovascular diseases. A large part of these effects are related to its antioxidant properties. Here we review: (a) the sources, the metabolism, and the bioavailability of resveratrol; (b) the ability of resveratrol to modulate redox signalling and to interact with multiple molecular targets of diverse intracellular pathways; (c) its protective effects against oxidative damage in cardio-cerebro-vascular districts and metabolic disorders such as diabetes; and (d) the evidence for its efficacy and toxicity in humans. The overall aim of this review is to discuss the frontiers in the field of resveratrol's mechanisms, bioactivity, biology, and health-related use.

Keywords: Antioxidant; Brain; Cardiovascular; Diabetes; Nitric oxide; Oxidative stress.

Publication types

  • Review

MeSH terms

  • Antioxidants / pharmacology*
  • Biological Availability
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / metabolism
  • Clinical Trials as Topic
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / metabolism
  • Humans
  • Metabolic Diseases / drug therapy*
  • Metabolic Diseases / metabolism
  • Oxidation-Reduction
  • Oxidative Stress / drug effects
  • Resveratrol
  • Stilbenes / pharmacokinetics
  • Stilbenes / pharmacology*

Substances

  • Antioxidants
  • Stilbenes
  • Resveratrol